"Topics in Anti-Cancer Research covers important advances on both experimental (preclinical) and clinical cancer research in drug development.  The book series offers readers an insight into current and future therapeutic approaches for the prevention of different types of cancers, synthesizing new anti-cancer agents, new patented compounds, targets and agents for cancer therapy as well as recent molecular and gene therapy research.
 
The comprehensive range of themes covered in each volume will be beneficial to clinicians, immunologists, and R&D experts looking for new anti-cancer targets and patents for the treatment of neoplasms, as well as varied approaches for cancer therapy.
 
The topics covered in the seventh volume of this series include:
- The role of ncRNAs in human cancer and its related patents
- Taxol to nanotaxol: a journey towards enhanced drug delivery
- Advanced therapy in cancer: stimuli-responsive nanocarriers for on-demand drug delivery
- The regulation and the function of autophagy in the development and behavior of esophageal cancers
- Recent patents on smart nano-formulations for cancer therapy
- Potential inflammatory mechanisms underlying chemotherapy-induced peripheral neuropathy and skeletal muscle effects
- Recent advances in nutrigenomics: patent applications
 "


Topics in Anti-Cancer Research: Volume 7

End User License Agreement (for non-institutional, personal use)

2. SMALL ncRNAs: miRNAs, piRNAs, tiRNAs, snoRNAs AND paRNAs

3. LONG ncRNAs: lincRNAs, T-UCRs, ceRNAs AND OTHER lncRNAs

The Role of ncRNAs in Human Cancer and its Related Patents

Taxol To Nanotaxol: A Journey Towards Enhanced Drug Delivery

3. EXTERNAL STIMULI-RESPONSIVE DRUG DELIVERY

4. INTERNAL STIMULI-RESPONSIVE DRUG DELIVERY

Advanced Therapy in Cancer: Stimuli-Responsive Nanocarriers for On-Demand Drug Delivery

The Regulation and the Function of Autophagy in the Development and Behavior of Esophageal Cancers

Recent Patents on Smart Nano-Formulations for Cancer Therapy

2. AN OVERVIEW OF CHEMOTHERAPY-INDUCED NEUROMUSCULAR EFFECTS

4. INFLAMMATION-ASSOCIATED MOLECULAR PATHWAYS OF INTEREST

5. GENETIC SUSCEPTIBILITY TO CHEMOTHERAPY-INDUCED NEUROMUSCULAR EFFECTS

6. CANCER-INDUCED AND CHEMOTHERAPY-INDUCED EFFECTS

7. RECENT DEVELOPMENTS IN THE TARGETING OF CHEMOTHERAPY-INDUCED NEUROMUSCULAR EFFECTS

Potential Inflammatory Mechanisms Underlying Chemotherapy-Induced Peripheral Neuropathy and Skeletal Muscle Effects

Recent Advances in Nutrigenomics: Patent Applications

Bentham Science Publishers

"Topics in Anti-Cancer Research covers important advances on both experimental (preclinical) and clinical cancer research in drug development.  The book series offers readers an insight into current and future therapeutic approaches for the prevention of different types of cancers, synthesizing new anti-cancer agents, new patented compounds, targets and agents for cancer therapy as well as recent molecular and gene therapy research.
 
The comprehensive range of themes covered in each volume will be beneficial to clinicians, immunologists, and R&D experts looking for new anti-cancer targets and patents for the treatment of neoplasms, as well as varied approaches for cancer therapy.
 
The topics covered in the sixth volume of this series include:
- The role of microtubules for the cure of various untreated cancers
- Novel chemoimmunotherapy drug combinations & methods in clinical studies/trials
- Targeting polyunsaturated fatty acids (PUFAs) in the treatment of colorectal cancer
- Anti-cancer activity of natural and synthetic chalcones and their derivatives
- Recent advances in microRNA-based cancer therapeutics
- The role of inflammation in chemotherapy-induced neuromuscular effects
- Recent patents for treating heart failure due to inflammation, mitochondria and energy metabolism in cancer cachexia"


Topics in Anti-Cancer Research: Volume 6

Atta-ur-Rahman

Khurshid Zaman

Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. It presents comprehensive articles written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations. Contributions are written by eminent scientists and each volume is edited by an authority in the field. Advances in Organic Synthesis is essential for all organic chemists in the academia and industry who wish to keep abreast of rapid and important developments in the field.


Advances in Organic Synthesis: Volume 6

"Topics in Anti-Cancer Research covers new developments in the field of cancer diagnosis and drug therapy. Novel drugs as anticancer agents include natural and synthetic phenazirines and other anti-cancer compounds. The series also covers information on the current understanding of the pathology and molecular biology of specific neoplasms.
 
The diversity of research topics published in this book series give broad and valuable perspectives for cancer researchers, clinicians, cancer professionals aiming to develop novel anti-cancer targets and patents for the treatment of various cancers.
 
The topics covered in this volume are:
- Peptides can play a major role in combating cancer diseases
- Studying of the CLL after treatment using fractal parameter of neoplastic lymphocytes detection (ΛNLD)
- Mechanistic insight of rhenium-based compounds as anti- cancer agents
- Targeting cancer-specific inflammatory components in cancer therapeutics
- Marine natural products as a source of novel anticancer agents: a treasure from the ocean
- PDX clinical trial design in anti-cancer research"


Topics in Anti-Cancer Research: Volume 10

"Frontiers in Clinical Drug Research – Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.
The fourth volume of this series features 5 reviews:
-TRP Channels: Potential Therapeutic Targets in Blood Disorders
-Hypercoagulable States: Clinical Symptoms, Laboratory Markers and Management
-Advanced Applications of Gene Therapy in the Treatment of Hematologic Disorders
-Ferroptosis - Importance and Potential Effects in Hematological Malignancies
-Clinical Application of Liquid Biopsy in Solid Tumor HCC: Prognostic, Diagnostic and Therapy Monitoring Tool"


Frontiers in Clinical Drug Research - Hematology: Volume 4

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
The sixth volume of this series features reviews that cover the following topics:
-Depression, Insomnia and Atypical Antidepressants
-Combination Therapy of Hypothermia for Hypoxic Encephalopathy in Neonates
-Development of A “Theranostic Nano-Bullet” for Tinnitus
-Dexmedetomidine: From Basic Science to Clinical Application of Brain Protection
-Protein Misfolding, Aggregation, Amyloid Formation in Neurodegenerative Diseases 
 "


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 6

Frontiers in Drug Design & Discovery Volume 11
 
Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists have contributed chapters focused on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. This book series should prove to be of interest to all pharmaceutical scientists who are involved in research in drug design and discovery and who wish to keep abreast of rapid and important developments in the field.
 
Volume 11 of this series brings together reviews covering immunotherapy of sepsis, new antimalarials, and the medicinal use of onions for respiratory diseases, among other topics.
 
Topics included in this volume are:
- Heme-oxygenase and autophagy connected as a cytoprotective mechanism: potential therapeutic target
- Development of recombinant therapeutic proteins in animal cells: Challenges and solutions 
- Artemisinin Analogues as a Novel Class of Antimalarial Agents: Recent Developments, Current Scenario and Future Perspectives
- The effects of Allium cepa and their derivatives on respiratory diseases and the possible mechanisms of these effects
- Immunotherapy of Sepsis

Frontiers in Drug Design & Discovery: Volume 11

Dr. M. lqbal Choudhary 

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
 
 
The seventh volume of this series features reviews that cover the following topics related to the treatment of neurodegenerative diseases, epilepsy and stroke:
 
-Fatty Acid Amides as a New Potential Therapeutic Agent in Multiple Sclerosis
 
-Epileptic Seizures Detection Based on Non-Linear Characteristics Coupled with Machine Learning Techniques
 
-Hampering Essential Tremor Neurodegeneration in Essential Tremor: Present and Future Directions
 
-The Potential Therapeutic Role of the Melatoninergic System in Treatment of Epilepsy and Comorbid Depression
 
-Modeling Neurodegenerative Diseases Using Transgenic Model of Drosophila
 
-Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors"


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 7

 Zareen Amtul

"Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
 
The fifth volume of this series features six reviews:
 
- Integrated Approaches for Marine Actinomycete Biodiscovery
 
- Therapeutic Use of Commensal Microbes: Fecal/Gut Microbiota Transplantation
 
- Alternative Approaches to Antimicrobials
 
- Nanoantibiotics: Recent Developments and Future
 
- Cranberry Juice and Other Functional Foods in Urinary Tract Infections in Women: A Review of Actual Evidence and Main Challenges
 
- Targeting Magnesium Homeostasis as Potential Anti-Infective Strategy Against Mycobacteria"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 5

"Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
 
The tenth volume of the series features chapters covering the following topics:
 
- Challenges in the Management of Hepatoblastoma
 
- The Emerging Role of Monocarboxylate Transporter-1 in Cancer
 
- In-vitro Anti-Proliferative Assays and Techniques Used in Pre-Clinical Anti-Cancer Drug Discovery
 
- Recent Advances in the Development of Mesoporous Anti-Cancer Drug Nanocarriers
 
- Polyphenols and Cancer
 
- Glioblastoma Multiforme
 
- Cutting Edge Targeting Strategies Utilizing Nanotechnology in Breast Cancer Therapy"


Frontiers in Anti-Cancer Drug Discovery: Volume 10

Advances in Organic Synthesis is abook series devoted to the latest advances in synthetic approaches towardschallenging structures. The series presents comprehensive reviews written byeminent authorities on different synthetic approaches to selected targetmolecules and new methods developed to achieve specific synthetictransformations or optimal product yields. Advances in Organic Synthesisis essential for all organic chemists in academia and the industry who wish tokeep abreast of rapid and important developments in the field. This volume presents the following reviews:Electroluminescent polymers - a review on synthesis from organic compoundsRemarkable advances in the asymmetric synthesis of biologically active natural compounds from the advent of chiral auxiliariesThe chemistry of ynamides and their application in organic synthesisCarbon-heteroatom bond formation for medium ring heterocyclesTin(ii) salts: versatile and efficient lewis acid catalysts in reactions to add value to the glycerol and terpenic alcohols(E)-n-methyl-1-(methylthio)-2-nitroethenamine (nmsm) as a versatile ambiphilic synthon in organic synthesis


Advances in Organic Synthesis: Volume 13

"Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
 
The seventh volume of this series features these interesting reviews:
- Nucleic acid and peptide aptamers as potential antiviral drugs
- Host-directed, antibiotic-adjuvant combination, and antibiotic-antibiotic combination for treating multidrug-resistant (mdr) gram-negative pathogens
- Bioactive substances as anti-infective strategies against clostridioides difficile
- Anti-toxoplasma drug discovery and natural products: a brief overview
- Development of antimalarial and antileishmanial drugs from amazonian biodiversity"


Votre panier

Topics in Anti-Cancer Research: Volume 7

$ 89.00

description_of_book

Informations supplémentaires

À propos des auteurs

Khurshid Zaman

Topics in Anti-Cancer Research: Volume 6

Khurshid Zaman

Atta-ur-Rahman

Atta-ur-Rahman